» Articles » PMID: 26552447

High Glucose Induces Renal Tubular Epithelial Injury Via Sirt1/NF-kappaB/microR-29/Keap1 Signal Pathway

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2015 Nov 11
PMID 26552447
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Diabetic nephropathy (DN) is a serious complication that commonly confronted by diabetic patients. A common theory for the pathogenesis of this renal dysfunction in diabetes is cell injury, inflammation as well as oxidative stress. In this content, the detailed molecular mechanism underlying high glucose induced renal tubular epithelial injury was elaborated.

Methods: An in vivo rat model of diabetes by injecting streptozotocin (STZ) and an in vitro high glucose incubated renal tubular epithelial cell (HK-2) model were used. Expression levels of Keap1, nuclear Nrf2 and p65 were determined by western blotting. Level of microR-29 (miR-29) was assessed using quantitative RT-PCR. Combination of p65 and miR-29 promotor was assessed using chromatin immunoprecipitation. Keap1 3'-UTR activity was detected using luciferase reporter gene assay. Cell viability was determined using MTT assay.

Results: In diabetic rat, miR-29 was downregulated and its expression is negatively correlated with both of serum creatinine and creatinine clearance. In high glucose incubated HK-2 cell, deacetylases activity of Sirt1 was attenuated that leads to decreased activity of nuclear factor kappa B (NF-κB). NF-κB was demonstrated to regulate miR-29 expression by directly binding to its promotor. The data of luciferase assay showed that miR-29 directly targets to Keap1 mRNA. While high glucose induced down regulation of miR-29 contributed to enhancement of Keap1 expression that finally reduced Nrf2 content by ubiquitinating Nrf2. Additionally, overexpression of miR-29 effectively relieved high glucose-reduced cell viability.

Conclusion: High glucose induces renal tubular epithelial injury via Sirt1/NF-κB/microR-29/Keap1 signal pathway.

Citing Articles

Sirtuins in kidney homeostasis and disease: where are we now?.

Fan Z, Wei X, Zhu X, Du Y Front Endocrinol (Lausanne). 2025; 15:1524674.

PMID: 39911234 PMC: 11794115. DOI: 10.3389/fendo.2024.1524674.


Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases.

Yu X, Chen M, Wu J, Song R Front Immunol. 2024; 15:1390907.

PMID: 38962006 PMC: 11219927. DOI: 10.3389/fimmu.2024.1390907.


Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases.

Xie T, Yao L, Li X Antioxidants (Basel). 2024; 13(6).

PMID: 38929098 PMC: 11200795. DOI: 10.3390/antiox13060659.


Exercise in Diabetic Nephropathy: Protective Effects and Molecular Mechanism.

Li R, Guo L Int J Mol Sci. 2024; 25(7).

PMID: 38612417 PMC: 11012151. DOI: 10.3390/ijms25073605.


Urinary microRNA in Diabetic Kidney Disease: A Literature Review.

Lee C, Chen C, Hsu C, Chen Y, Chen C, Yang K Medicina (Kaunas). 2023; 59(2).

PMID: 36837555 PMC: 9962090. DOI: 10.3390/medicina59020354.


References
1.
Nakagawa T, Tanabe K, Croker B, Johnson R, Grant M, Kosugi T . Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol. 2010; 7(1):36-44. PMC: 3653134. DOI: 10.1038/nrneph.2010.152. View

2.
Smith J, Kenney R, Gagne D, Frushour B, Ladd W, Galonek H . Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst Biol. 2009; 3:31. PMC: 2660283. DOI: 10.1186/1752-0509-3-31. View

3.
Jenkin K, McAinch A, Zhang Y, Kelly D, Hryciw D . Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions. Clin Exp Pharmacol Physiol. 2014; 42(3):256-62. DOI: 10.1111/1440-1681.12355. View

4.
Zheng H, Whitman S, Wu W, Wondrak G, Wong P, Fang D . Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes. 2011; 60(11):3055-66. PMC: 3198067. DOI: 10.2337/db11-0807. View

5.
Ceolotto G, de Kreutzenberg S, Cattelan A, Fabricio A, Squarcina E, Gion M . Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome. Clin Sci (Lond). 2014; 127(7):449-61. DOI: 10.1042/CS20130439. View